Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Recovery of Heart Rate Variability in Handball Players (HRV-HANDBAll)

30 de agosto de 2026 atualizado por: Ramiz ARABACI, Uludag University

Effects of Manual Massage and Foam Rolling on Heart Rate Variability Following 20m-Shuttle Run Test in Elite Male Handball Players

This study aimed to compare the acute effects of manual massage (MM) and foam rolling (FR) on heart rate variability (HRV) following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during

Visão geral do estudo

Descrição detalhada

The aim of present study was to compare the acute effects of manual massage (MM) and foam rolling (FR) on time-domain and frequency-domain HRV parameters following a 20 m shuttle run test (20m-SRT) in elite male handball players. It was hypothesized that MM and FR would produce differential acute effects on HRV responses during. Fifteen elite male handball players voluntarilly participated in present study.

The research utilized a randomized cross-over design. All participants provided written informed consent after being briefed about the aims, procedures, benefits, and risks. Study was conducted in three sessions in onwe week. Fırst session is familiarization, other two sessions are experimental: MM and FR sessions. Participants were instructed to maintain their normal diet, refrain from intense exercise for at least 48 hours before study sessions, avoid alcohol and caffeine intake for 24 hours prior, and consume their last meal at least 3 hours before sessions. In familiarization session, subjects fulfilled Exercise Readiness Questionnaire (EGZ+), measured body composition, after warm-up 20m-SRT, and recovery interventions (MM and FR). Before warm-up - pre-test, during 20-m shuttle run test - test and after recovery - post-test HRV were recorded. In experimental session, after the 20 min standard warm-up including jogging, jumping and stretching volunteers performed 20m-SRT and immediately one of two different recovery interventions. Recovery interventions are MM and FR applied on the lower extremities. All procedures were conducted at the same time of day (14:00-16:00) to minimize circadian rhythm effects. To determine differences in HRV and heart rate across recovery methods and time points, a Two Way Repeated Measures ANOVA was used: 2 Intervention (MM and FR) × 3 Time (Pre-test, Test, Post-test). Bonferroni-adjusted pairwise comparisons performed to identify differences between specific time points and interventions.

Tipo de estudo

Intervencional

Inscrição (Real)

15

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Bursa, Turquia (Türkiye), 16059
        • Bursa uludag University, Faculty of Sport Sciences

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Male handball players competing in the Turkish Handball Super League
  • At least 5 years of regular handball training experience
  • Participation in at least 10 official matches during the previous 12 months
  • Minimum 1 year of playing experience in the Turkish Handball Super League
  • No injury resulting in an interruption of training or competition for more than 2 weeks during the previous 6 months
  • No use of stimulants, ergogenic aids, or prohibited performance-enhancing substances

Exclusion Criteria:

  • Current musculoskeletal injury or pain affecting training or match participation
  • History of surgery to the lower or upper extremities within the previous 12 months
  • Presence of cardiovascular, neurological, or metabolic disorders
  • Use of medications that may affect physical performance or neuromuscular function
  • Inability to complete the study procedures or testing protocol
  • Withdrawal of informed consent

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Manual Massage (MM)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Manual Massage (MM) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and MM HRV was recorded.
MM protocol employed Swedish massage techniques (Hemmings, 2001; Tessier, 2005), including effleurage (light stroking), friction, petrissage (kneading and rolling), vibration and tapotement (light percussion). Massage was applied for 20 minutes total, distributed as: 10 minutes on the right and 10 minutes on the left lower extremity. Posterior lower-extremity massage included the gluteal region, posterior thigh, and calf muscles. Anterior lower-extremity massage included only the quadriceps. Applications were performed from distal to proximal direction using baby oil by certified masseur. Anterior leg massage in a supine position and posterior leg massage in a prone position was applied
Experimental: Foam Rolling (FR)
After the 20 minute standard warm-up including jogging, jumping and stretching participant performed 20 m Shuttle Run Test (20m-SRT), subsequently legs Foam Rolling (FR) recovery intervention lasted 20 minutes. Before warm-up, during 20m-SRT and FR HRV was recorded.
A medium density, grid structured foam roller (Blackroll Standard, 33×15×14 cm, PVC polypropylene, Bottighofen, Switzerland) was used. Participants performed self-myofascial release by placing the lower extremities on the foam roller and rolling forward and backward to relax fascia surrounding the muscle with medium pressure. Total duration of FR lasted 20 minutes: 10 minutes left and 10 minutes right lower extremity. Rolling was performed at a controlled cadence (~30 cycles/min) guided by a metronome with moderate pressure.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Heart Rate Variability (HRV)
Prazo: From enrollment to the end of treatment at 60 minutes
HRV was recorded by Polar V800 (Polar Electro, Kempele, Finland) heart rate monitor and chest strap of Polar H10 transmitter. HRV time-domain (RR, RMSSD, SDNN) and frequency-domain (VLF, LF, HF) markers and heart rate (HR) were recorded and transferred in Polar Flow. Data set normalized by adopting artefact methodology using Kubios HRV Scientific (Tarvainen et al., 2014). Power values were calculated in normalized units (n.u.). HRV recordings were obtained during three phases: pre exercise (10 min supine rest), during exercise and post exercise recovery phases (10 min supine rest. Participants were instructed to maintain spontaneous but stable breathing during recordings.
From enrollment to the end of treatment at 60 minutes
20 m Shuttle Run Test (VO2max)
Prazo: After warm-up 20m-SRT lasted approximately 12-15 minute
20m-SRT was administered following the protocol of Leger and Lambert (1982). The running pace was controlled by "beep test" audio signals. The test started at a speed of 8.5 km·h-¹, increasing by 0.5 km·h-¹ every minute. Participants were required to cover 20 m at each signal. The test ended when a participant failed to complete the 20 m distance three consecutive times. Estimated VO2max values were calculated using the Leger et al. (1988) formula.
After warm-up 20m-SRT lasted approximately 12-15 minute

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Height
Prazo: 1 minute during familiarisation session
Standing height was measured with a SECA 216 digital stadiometer with a precision of 0.01 m.
1 minute during familiarisation session
Weight
Prazo: 1 minute during familiarisation session
Body weight (kg) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Total Body Fat
Prazo: 1 minute during familiarisation session
Total body fat (%) were measured using a TANITA BC 418MA Segmental Body Composition Analyzer (±0.50 kg accuracy).
1 minute during familiarisation session
Body Mass Index
Prazo: 1 minute during familiarisation session
Weight and height will be combined to report BMI in kg/m^2
1 minute during familiarisation session

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de maio de 2025

Conclusão Primária (Real)

30 de junho de 2025

Conclusão do estudo (Real)

31 de julho de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

3 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de junho de 2026

Primeira postagem (Real)

15 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

2 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

30 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2023-20/71014

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

only IPD used in the results publication

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever